Stay updated on BA3021 in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the BA3021 in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BA3021 in Head and Neck Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Locations were reorganized and expanded: a consolidated Locations section now lists sites in CA, DE, IL, KY, MO, NY, and UT, replacing the previous state-specific headings. The page revision updated to v3.3.3.
    Difference
    0.8%
    Check dated 2025-12-17T17:51:46.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    - Revision tag updated from v3.2.0 to v3.3.2 on the page.
    Difference
    0.1%
    Check dated 2025-12-03T12:16:30.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Removed: a banner/notice regarding government funding lapse and NIH operating status from the page. This deletion does not affect the actual study details, eligibility criteria, or reported outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-19T01:42:18.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Study status updated to Completed with primary completion and study completion dates listed as 2025-09-22. Enrollment is shown as 42 across seven locations in the United States.
    Difference
    0.4%
    Check dated 2025-10-28T02:39:08.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The page now includes a funding-status notice and a current operating status link, and updates the revision to v3.2.0 while removing the older Last Update Posted label and v3.1.0.
    Difference
    4%
    Check dated 2025-10-06T16:00:00.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    New Phase 2 Ozuriftamab Vedotin study added with current dates and 7 locations; older recruitment details, contacts, and Oregon-specific listings removed. Overall, page content now centers on the updated Phase 2 trial information.
    Difference
    8%
    Check dated 2025-09-29T09:54:42.000Z thumbnail image

Stay in the know with updates to BA3021 in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BA3021 in Head and Neck Cancer Clinical Trial page.